VERAXA Biotech and Quadira Biosciences Enter Partnership on ADC Development
Search jobs VERAXA Biotech and Quadira Biosciences Enter Partnership on ADC Development HEIDELBERG, Germany and ZUG, Switzerland, June 14, 2021 / B3C newswire / --VERAXA Biotech GmbH (former Velabs Therapeutics GmbH), a leading company in innovative ADC engineering and functional antibody screening, announced today that it has entered into a partnership agreement with Quadira Biosciences AG, Zug, Switzerland, to jointly develop a suite of novel ADCs for the treatment of oncological conditions. The collaboration will leverage both the advantages of VERAXA's advanced an...
Source: pharmiweb.com